Dyslipidaemias Clinical Trial
Official title:
Food Effect Study of GSK256073A in Healthy Subjects
The purpose of this study is to compare the effects of fasting and fed conditions with repeat doses of GSK256073F in HVT subjects.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00783549 -
A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.
|
Phase 1 | |
Completed |
NCT01218204 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
|
Phase 2 | |
Completed |
NCT00551694 -
A Second Study to Determine the Effect of GSK256073A on HVTs
|
Phase 1 | |
Completed |
NCT00169559 -
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
|
Phase 2 | |
Completed |
NCT00488449 -
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00903617 -
Study to Test GSK256073 in Patients With Dyslipidemia
|
Phase 2 | |
Completed |
NCT00474864 -
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
|
Phase 2 | |
Completed |
NCT00608699 -
A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT00318617 -
Effect Of GW501516X On How The Heart Obtains And Uses Energy
|
N/A | |
Completed |
NCT00388180 -
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
|
N/A | |
Completed |
NCT00158899 -
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
|
Phase 2 |